• 155 Citations
  • 8 h-Index
19972018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Carmen Garganese is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Neuroblastoma Medicine & Life Sciences
Radionuclide Imaging Medicine & Life Sciences
Nuclear Medicine Medicine & Life Sciences
3-Iodobenzylguanidine Medicine & Life Sciences
Thyroid Neoplasms Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Osteoid Osteoma Medicine & Life Sciences
Topotecan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

  • 155 Citations
  • 8 h-Index
  • 24 Article
  • 1 Chapter
Whole Body Imaging
Thyroid Neoplasms
Iodine
Lymph Nodes
Thyroglobulin
3 Citations (Scopus)

Anakinra in a cohort of children with chronic nonbacterial osteomyelitis

Pardeo, M., Marafon, D. P., Messia, V., Garganese, M. C., De Benedetti, F. & Insalaco, A., Aug 1 2017, In : Journal of Rheumatology. 44, 8, p. 1231-1238 8 p.

Research output: Contribution to journalArticle

Interleukin 1 Receptor Antagonist Protein
Osteomyelitis
Bone and Bones
Blood Sedimentation
Radionuclide Imaging

A pediatric case of well-functioning supernumerary kidney

Pizzoferro, M., Lo Zupone, C., De Gennaro, M., Villani, M. F. & Garganese, M. C., Sep 1 2017, In : Clinical Nuclear Medicine. 42, 9, p. 685-686 2 p.

Research output: Contribution to journalArticle

Succimer
Pediatrics
Kidney
Radionuclide Imaging
Abdomen

Unusual Presentation of Relapse in Neuroblastoma: Pancreatic Metastases Detected by 123I-MIBG Scintigraphy

Villani, M. F., D’Andrea, M. L., Castellano, A., Pizzoferro, M. & Garganese, M. C., May 19 2017, (Accepted/In press) In : Clinical Nuclear Medicine.

Research output: Contribution to journalArticle

3-Iodobenzylguanidine
Neuroblastoma
Radionuclide Imaging
Neoplasm Metastasis
Recurrence
13 Citations (Scopus)
Neuroblastoma
Drug Therapy
Multivariate Analysis
Survival
Proportional Hazards Models